Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug

Background: COVID-19 disease caused by SARS-CoV-2 is lacking efficient medication although certain medications are used to relief its symptoms. Objectives: We tested an FDA-approved antiviral medication namely rilpivirine to find a drug against SARS-CoV-2. Methods: The inhibition of rilpivirine agai...

Full description

Saved in:
Bibliographic Details
Main Authors: Fuad Ameen (Author), Estari Mamidala (Author), Rakesh Davella (Author), Shravan Vallala (Author)
Format: Book
Published: Elsevier, 2021-10-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available